CDKN2A and melanoma: O’Neill et al. presented the case of a 74-year-old man with a rhabdomyosarcomatous melanoma bearing NRAS, TERTp, CDKN2A, NF1, FGFR2, CBL, BLM, and TP53 mutations [38].